NKTX vs WST · $188.9M cap vs P/E 35, rev $1.72B
Nkarta Inc (NKTX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
NKTX currently screens at market cap $188.9M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the NKTX and WST stock pages for the full models.
Not investment advice.